Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer.
Rihito AizawaKenji TakayamaKiyonao NakamuraTakahiro InoueTakashi KobayashiShusuke AkamatsuToshinari YamasakiOsamu OgawaTakashi MizowakiPublished in: International journal of clinical oncology (2018)
Definitive EBRT achieved a long-term disease-free and clinical failure-free status in approximately one-third of and half of the treated NM-CRPC patients, respectively. This approach was also associated with favorable local relapse-free rates and overall survival outcomes. Definitive EBRT is a promising approach for NM-CRPC patients.